Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (12) · 1705-1706
DOI: 10.1111/apt.70715 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-05-12. Written by José Luis Rueda García and 3 co-authors. Institution: Gastroenterology, La Paz University Hospital, Madrid, Spain. 2 references.
Abstract (original language)
Ebda abstract disponibbli.
Authors and institutions
- Gastroenterology, La Paz University Hospital, Madrid, Spain.
- IdiPAZ Study Group on Immune-Mediated Gastrointestinal Diseases, La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
- Gastroenterology, Hospital Universitari Mútua Terrassa, Terrassa, Catalonia, Spain.
- Centro de investigación biomédica en Red de Enfermedades Hepáticas y Digestivas (CiberEHD), Madrid, Spain.
ORCID profiles: José Luis Rueda García, Cristina Suárez-Ferrer, Yamile Zabana
Cite
APA
García, J. L. R., Suárez-Ferrer, C., Zabana, Y., & Young Group of GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis) (2026). Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(12), 1705-1706. https://doi.org/10.1111/apt.70715
Vancouver
García JLR, Suárez-Ferrer C, Zabana Y, Young Group of GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis). Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(12):1705-1706. doi:10.1111/apt.70715
BibTeX
@article{Garca2026,
author = {García, José Luis Rueda and Suárez-Ferrer, Cristina and Zabana, Yamile and Young Group of GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis), Young Group of GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis)},
title = {Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {12},
pages = {1705--1706},
doi = {10.1111/apt.70715}
}
EUVIMED